Owen Mumford introduces 16G safety lancet into Unistik Touch range
New 16G size designed for high volume blood sampling for HCPs and test kit manufacturers producing home sampling kits
Owen Mumford, a global leader in the design, manufacture and advancement of medical technology, today announced it has introduced a 16-gauge (16G) safety lancet for high-volume capillary blood sampling into its leading Unistik product range. The new Unistik® Touch 16G has one-touch activation and Comfort Zone Technology® that minimises the pain of finger sampling.1
The new safety lancet has been designed for healthcare professionals (HCPs) and test kit manufacturers. For HCPs who need to perform higher volume blood sampling on patients for a wide range of tests including blood gas, electrolytes, blood coagulation, total bilirubin and cardiac markers, it can be used in a variety of clinical settings and offers the benefit of fewer punctures for higher blood volumes.
It is also ideally suited for at-home and point of care testing (POCT) kits, making it a convenient choice for test kit inclusion by kit manufacturers who require reduced packaging, bulk order quantities and can benefit from its small form and simple user features.
The Unistik Touch 16G one-touch activation feature requires the user to simply press the device against the sample site. Activated automatically, the needle then retracts into the body of the device, minimising the risk of re-use, pre-analytical errors for multiplex tests, cross infection and needlestick injuries.
“The Unistik Touch range was developed in-house to make sampling more comfortable for patients and easier for HCPs to successfully obtain the right amount of blood first-time,” said Jesper Jonsson, Director of Medical Devices at Owen Mumford. “Our proven pain-minimising technology and simple one-touch activation makes it a very attractive option and the 16G lancet has been developed and priced competitively to ensure the same benefits in patient comfort can be offered within the growing at-home testing and POCT markets. This new solution for high volume blood sampling perfectly complements our portfolio so we can offer the market an even wider choice of safety lancet.”
The Unistik Touch 16G is available in a range of packaging configurations including 100ct, 200ct and bulk volumes. Further educational material has been created in collaboration with HCPs and key opinion leaders to support everyone in achieving reliable test results.
For more information on Unistik Touch 16G go to: https://www.owenmumford.com/en/healthcare-professionals-product/unistik-touch/
1. Melzack, R. and Wall, P. The Challenge of Pain. Harmondsworth, UK: Penguin; 1982, p233.]
More in Health
Activate Business School launches new education programme for aspiring health leaders
Activate Business School is delighted to announce it is launching a new award to help develop and train health and care staff across Buckinghamshire Oxfordshire and Berkshire (BOB).
CEO FOCUS: Take Your Best Shot
A fascinating interview with Thomas Hal Robson-Kanu, international professional football player and founder of The Turmeric Co, one of the UK’s fastest growing health brands.
Blenheim to Host European Transplant and Dialysis Games
Blenheim is set to host three days of competition as part of the European Transplant and Dialysis Games which will arrive in the UK next week (23rd-25th August) for the first time ever.
From this author
Owen Mumford’s Near-Term and Net-Zero targets approved by the SBTi
Owen Mumford, a leader in the medical device industry and certified B Corp, has announced that the Science Based Targets initiative (SBTi) has approved its near-term science-based emissions reduction target. The medical device manufacturer has also committed to set long-term emissions reduction targets with the SBTi in line with reaching net-zero by 2045 – 5 years ahead of the UK’s net-zero target.
Owen Mumford acquires Empelvic
Owen Mumford Expands Pelvic Health Portfolio with Acquisition of Empelvic
Owen Mumford partners with Duopharma Biotech to distribute medical devices
Partnership with leading pharmaceutical company will supply diabetes and eye care devices in the Malaysia and Brunei markets